Use of Gla-100 in Special Situations

Area of Science:

• Endocrinology
• Metabolic Diseases
• Pharmacology

Background:

• Insulin therapy is fundamental for managing type 2 diabetes mellitus (T2DM).
• Its application extends to diverse patient groups including the elderly, pregnant women, obese individuals, those fasting, and patients with comorbidities like renal insufficiency or cancer.
• These specific circumstances increase the risk of complications, particularly hypoglycemia, necessitating careful glucose monitoring and insulin dose titration.

Purpose of the Study:

• To review decision-making considerations for insulin therapy in special T2DM populations.
• To highlight the role and benefits of insulin glargine 100 U/mL in these contexts.

Main Methods:

• Literature review focusing on insulin therapy in special populations with T2DM.
• Analysis of clinical considerations and evidence supporting specific insulin choices.

Main Results:

• Special populations require tailored insulin management strategies to mitigate hypoglycemia risks.
• Insulin glargine 100 U/mL demonstrates a favorable profile with low hypoglycemia and weight gain potential.
• This profile supports its recommendation in recent diabetes guidelines for these patients.

Conclusions:

• Careful insulin therapy adjustments are vital for patients with T2DM in special situations.
• Insulin glargine 100 U/mL offers a safe and effective option, aligning with current clinical guidelines.